Sinphar Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Sinphar Pharmaceutical Co Ltd cash flow-to-debt ratio. Sinphar Pharmaceutical Co Ltd (1734) has a Cash Flow-to-Debt Ratio of 0.04x as of March 2026, meaning its operating cash flow of NT$116.42 Million could theoretically repay 0% of its total liabilities (NT$2.61 Billion) in one year. Check cash flow reinvestment rate of Sinphar Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sinphar Pharmaceutical Co Ltd (2003–2025)
Cash flow-to-debt ratio of Sinphar Pharmaceutical Co Ltd from 2003 to 2025. Historical debt coverage capacity for Sinphar Pharmaceutical Co Ltd across 23 annual periods. Check Sinphar Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sinphar Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2003–2025)
Sinphar Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2003 to 2025. Year-by-year debt coverage analysis for Sinphar Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Sinphar Pharmaceutical Co Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | NT$584.66 Million | NT$2.44 Billion | ▲ +11.2% |
| 2024 | 0.22x | NT$593.51 Million | NT$2.75 Billion | ▲ +107.6% |
| 2023 | 0.10x | NT$296.37 Million | NT$2.85 Billion | ▼ -27.5% |
| 2022 | 0.14x | NT$425.30 Million | NT$2.97 Billion | ▲ +232.3% |
| 2021 | 0.04x | NT$135.54 Million | NT$3.14 Billion | ▼ -12.1% |
| 2020 | 0.05x | NT$146.39 Million | NT$2.98 Billion | ▲ +267.5% |
| 2019 | -0.03x | NT$-79.49 Million | NT$2.71 Billion | ▼ -190.5% |
| 2018 | 0.03x | NT$79.50 Million | NT$2.46 Billion | ▼ -64.4% |
| 2017 | 0.09x | NT$219.87 Million | NT$2.42 Billion | ▲ +153.0% |
| 2016 | 0.04x | NT$87.18 Million | NT$2.42 Billion | ▼ -68.9% |
| 2015 | 0.12x | NT$280.53 Million | NT$2.43 Billion | ▲ +85.6% |
| 2014 | 0.06x | NT$148.58 Million | NT$2.39 Billion | ▼ -53.7% |
| 2013 | 0.13x | NT$297.09 Million | NT$2.21 Billion | ▲ +50.9% |
| 2012 | 0.09x | NT$164.45 Million | NT$1.85 Billion | ▼ -21.9% |
| 2011 | 0.11x | NT$225.58 Million | NT$1.98 Billion | ▼ -32.3% |
| 2010 | 0.17x | NT$261.49 Million | NT$1.55 Billion | ▼ -19.0% |
| 2009 | 0.21x | NT$309.94 Million | NT$1.49 Billion | ▲ +39.5% |
| 2008 | 0.15x | NT$271.01 Million | NT$1.82 Billion | ▲ +24.8% |
| 2007 | 0.12x | NT$174.85 Million | NT$1.46 Billion | ▼ -20.4% |
| 2006 | 0.15x | NT$166.57 Million | NT$1.11 Billion | ▲ +46.7% |
| 2005 | 0.10x | NT$122.09 Million | NT$1.19 Billion | ▼ -39.8% |
| 2004 | 0.17x | NT$174.81 Million | NT$1.03 Billion | ▲ +56.9% |
| 2003 | 0.11x | NT$120.84 Million | NT$1.12 Billion | — |